ArticleCureus2026
Systemic Oxidative and Protein Profile Dysregulation in Tobacco-Associated Oral Malignancy and Precancerous Conditions.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Tobacco-related oral carcinogenesis is a complex multistep process characterized by early biochemical and metabolic disturbances that occur before the appearance of clinically detectable diseases. This study aimed to assess and compare the systemic levels of glutathione (GSH), total plasma protein, and albumin among individuals with tobacco-associated oral cancer, individuals with potentially malignant oral disorders, and tobacco users without oral lesions. Materials and methods This cross-sectional study included 90 participants: 30 patients with oral cancer, 30 with potentially malignant oral disorders (oral submucous fibrosis and leukoplakia), and 30 healthy tobacco users serving as controls. Venous blood samples were collected under sterile conditions following a thorough clinical evaluation. Plasma GSH, total protein, and albumin concentrations were determined using standardized biochemical assays. Statistical analyses were then performed. Results Mean GSH levels were significantly elevated in the oral cancer group (9.23 ± 1.35 mg/dL) compared to the precancerous (4.78 ± 1.27 mg/dL) and control groups (2.67 ± 0.73 mg/dL) (p = 0.001). In contrast, total protein levels were highest among controls (7.25 ± 0.43 g/dL), followed by the precancerous group (6.78 ± 0.67 g/dL), and were lowest in patients with oral cancer (6.56 ± 0.47 g/dL) (p = 0.001). Albumin concentrations showed a similar declining trend, with significantly reduced values in the oral cancer group (3.43 ± 0.47 g/dL) compared to the precancerous (3.84 ± 0.47 g/dL) and control groups (4.00 ± 0.32 g/dL) (p = 0.001). Conclusion Alterations in systemic antioxidant status and protein profiles, particularly increased GSH and reduced albumin and total protein levels, may reflect early biochemical changes associated with malignant progression in tobacco users. Therefore, these markers may have potential utility in early risk assessment and preventive oral health interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.